AXQ Capital’s Boston Scientific BSX Stock Holding History

AXQ Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.19M	Buy	121,522 +21,466	+21%	+$1.17M	0.56%	18
2026 Q1	$6.28M	Buy	100,056 +87,509	+697%	+$7M	0.81%	1
2025 Q4	$1.2M	Sell	12,547 -2,145	-15%	-$210K	0.27%	110
2025 Q3	$1.43M	Buy	+14,692	New	+$1.52M	0.55%	21
2025 Q2	–	Sell	-15,218	Closed	-$1.54M	–	591
2025 Q1	$1.54M	Buy	+15,218	New	+$1.53M	0.62%	18
2024 Q4	–	Sell	-12,534	Closed	-$1.05M	–	448
2024 Q3	$1.05M	Sell	12,534 -13,260	-51%	-$1.05M	0.32%	120
2024 Q2	$1.99M	Buy	25,794 +7,694	+43%	+$563K	0.46%	56
2024 Q1	$1.24M	Buy	+18,100	New	+$1.16M	0.3%	99
2023 Q4	–	Sell	-24,600	Closed	-$1.3M	–	654
2023 Q3	$1.3M	Buy	24,600 +15,910	+183%	+$834K	0.46%	52
2023 Q2	$470K	Buy	+8,690	New	+$454K	0.58%	43
2023 Q1	–	Sell	-7,000	Closed	-$324K	–	492
2022 Q4	$324K	Buy	+7,000	New	+$303K	0.23%	173

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AXQ Capital's BSX Position: Q2 2026 in Review

AXQ Capital increased its Boston Scientific (BSX) stake by 21% in Q2 2026, buying an estimated $1.17M and bringing the position to 121,522 shares worth $5.19M. The position accounts for 0.56% of the portfolio, ranked #18.

AXQ Capital first reported a position in BSX in Q4 2022 and has held it in 11 quarters since. The position peaked at $6.28M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

AXQ Capital held 121,522 shares of Boston Scientific worth $5.19M as of Q2 2026.
AXQ Capital bought 21,466 Boston Scientific shares in Q2 2026, an estimated $1.17M.
Boston Scientific made up 0.56% of AXQ Capital's portfolio in Q2 2026, its #18 holding.
AXQ Capital first reported a position in Boston Scientific in Q4 2022 and has held it in 11 quarters since.
AXQ Capital's Boston Scientific position peaked at $6.28M in Q1 2026.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.